Use of finerenone for heart failure with preserved ejection fraction carries a hyperkalemia risk, especially in patients with kidney disease.

Resin therapy was found to be effective in controlling hyperkalemia in these patients with either oral or rectal administration of this drug. No serious toxic effects were observed. From the ...

Common causes of hyperkalemia in the tropics are snake, wasp or hornet bites and heat stroke. In patients with malaria, hyperkalemia usually occurs in the presence of metabolic acidosis and is ...

Finerenone use in trial patients with HFpEF or HFmrEF increased hyperkalemia risk, especially in those with CKD. Finerenone use in patients with heart failure and preserved or mildly reduced ...

During the open-label run-in period, patients underwent spironolactone titration, with a target to 50 mg/daily, and those with hyperkalemia started SZC. Patients with normokalemia (potassium 3.5-5 ...

This rare phenomenon, known as the Littmann sign, can also occur in hyperkalemia. After immediate initiation of medication and a short period of when the patient’s heart rate fell to 20 bpm ...

The following is a summary of “Sodium Zirconium Cyclosilicate for Management of Hyperkalemia During Spironolactone ...

The primary risk of eplerenone is hyperkalemia (which can cause serious arrhythmias). Periodic monitoring of potassium levels is recommended for patients at risk of developing hyperkalemia.

It usually gets into your body through foods you eat, medications, or IV infusions. Hyperkalemia happens when there's too much potassium in your bloodstream. It's stored inside your nerve and ...

The software leverages Lead I ECG data to notify patients and healthcare providers of moderate to severe hyperkalemia episodes, which may result in sudden cardiac arrest. .In 2023, the diagnosed ...

The investigational technology uses Lead I ECG data to alert patients and clinicians of moderate to severe episodes of hyperkalemia (excess potassium in the blood) that can lead to sudden cardiac ...